Connect with us
[bsa_pro_ad_space id=12]

International

‘Tripping, Freezing, Forgetting’: Foreign Media Says ‘Distracted’ Biden Is Getting Worse Ahead Of 2024 Election

Published

7 minute read

From the Daily Caller News Foundation

By JAKE SMITH

 

Several foreign media outlets have published stories in recent months raising concern about President Joe Biden’s health ahead of the 2024 U.S. presidential election.

Biden and his administration maintain that his health is in stable condition and that he is capable of defeating former President Donald Trump in November. But Biden’s recent performance, remarks during press briefings and on-camera appearances have been called into question by a number of major international media outlets, who point to the increasing concern among U.S. voters about his age and mental status.

“Biden isn’t the man he used to be,” a June editorial story from The Independent, a U.K. newspaper, reads. “A failure to take the mounting evidence seriously risks not only a collapse of trust in the White House that will affect future presidents but the specter of real crises during a second Biden term.”

“[Biden has an] inability to function well,” a news story published on Monday by the Hindustan Times, an Indian outlet, reads. “He has come under the spotlight several times for his gaffes, mixing up names of people, and struggling to recall simple words,” reads a separate piece from March.

Biden and his campaign team have downplayed age and health concerns, sometimes leaning into his age as a positive given his decades of political experience. Regardless, Biden’s fitness has remained an issue among swaths of voters; a New York Times/Siena poll conducted in March found that over 70% of voters believed that Biden’s age makes him “ineffective” or incapable of handling the duties of the Oval Office.

“Biden’s main opposition has come from anxiety over his age and health,” a news story in the Chinese-state media outlet Global Times from March reads.

International media outlets especially covered concerns surrounding Biden after Department of Justice Special Counsel Robert Hur released a report in February regarding Biden’s possible mishandling of classified documents. The report recommended not pursuing charges against Biden because he presented himself as a “well-meaning, elderly man with a poor memory” and a jury would likely find him not guilty.

Biden held a press conference the same day the report was released and criticized Hur’s report, but made a series of slip-ups during remarks and shouted at reporters, which some media outlets claimed highlighted Hur’s findings.

“The events underscore the unenviable challenge facing Biden’s aides, who know every verbal slip can exacerbate the biggest liability the president faces — voters worrying he’s not up to the task,” a editorial story from The Japan Times in February reads, claiming that the Biden campaign is “attempting to make it to November free of major gaffes.”

“The numerous references in the report to Joe Biden’s failing memory… give unprecedented force to questions about his physical and mental capacity to stand again,” a news story from French outlet Le Monde wrote about the Hur report. “The worrying episodes are increasing.”

Biden’s behavior was called into question by a number of foreign media outlets at the Group of Seven G7 summit on Friday, in which he stood alongside the leaders of the other G7 nations for a photograph before appearing to wander off and be brought back to the group by Italian Prime Minister Giorgia Meloni.

“Joe Biden’s ‘unusual behavior’ at the G7 leaves leaders ‘alarmed’ and ‘bemused,’” a Monday news headline from Sky News Australia reads.

“The video was widely circulated on social media and sparked debate, with some questioning Biden’s ability to serve another term,” a news story from India Today on Friday reads, claiming that Biden has appeared “dazed” in recent public appearances.

A Pew Global Research survey published on June 11 found that international confidence in Biden’s ability to conduct foreign policy is falling; adults surveyed in 14 nations including Israel, Japan, the U.K. and Australia said their confidence in Biden had “dropped significantly” since 2023. Less than half of respondents in dozens of countries surveyed said that Biden is properly handling the global conflicts of the Russia-Ukraine and Israel-Hamas wars.

The large survey was conducted with thousands of respondents across dozens of countries. The typical margin of error for each country’s survey was between 0% and 5%.

Biden’s mental and physical fitness has been the subject of constant attacks by Trump and his campaign team ahead of the elections in November. The two are expected to face off on the debate stage in Atlanta, Georgia, on June 27.

“Amid the urgent issues for discussion in the first debate between the candidates in the forthcoming US presidential election, age is being weaponized by both contenders,” a Telegraph editorial story on Sunday reads. “But Biden, perhaps distracted by Presidential duties… is late to the party when it comes to throwing shade on a person for being old. His apparent lapses – tripping, freezing, forgetting people’s names, and aimless wandering – most recently at last week’s G7 meeting in Italy – have been gleefully exploited by his opponents.”

The White House did not immediately respond to a request for comment.

(Featured Image Media Credit: Official White House Photo by Cameron Smith)

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

Business

RFK Jr. planning new restrictions on drug advertising: report

Published on

MXM logo MxM News

Quick Hit:

The Trump administration is reportedly weighing new restrictions on pharmaceutical ads—an effort long backed by Health Secretary Robert F. Kennedy Jr. Proposals include stricter disclosure rules and ending tax breaks.

Key Details:

  • Two key proposals under review: requiring longer side-effect disclosures in TV ads and removing pharma’s tax deduction for ad spending.

  • In 2024, drug companies spent $10.8 billion on direct-to-consumer ads, with AbbVie and Pfizer among the top spenders.

  • RFK Jr. and HHS officials say the goal is to restore “rigorous oversight” over drug promotions, though no final decision has been made.

Diving Deeper:

According to a Bloomberg report, the Trump administration is advancing plans to rein in direct-to-consumer pharmaceutical advertising—a practice legal only in the U.S. and New Zealand. Rather than banning the ads outright, which could lead to lawsuits, officials are eyeing legal and financial hurdles to limit their spread. These include mandating extended disclosures of side effects and ending tax deductions for ad spending—two measures that could severely limit ad volume, especially on TV.

Health and Human Services Secretary Robert F. Kennedy Jr., who has long called for tougher restrictions on drug marketing, is closely aligned with the effort. “We are exploring ways to restore more rigorous oversight and improve the quality of information presented to American consumers,” said HHS spokesman Andrew Nixon in a written statement. Kennedy himself told Sen. Josh Hawley in May that an announcement on tax policy changes could come “within the next few weeks.”

The ad market at stake is enormous. Drugmakers spent $10.8 billion last year promoting treatments directly to consumers, per data from MediaRadar. AbbVie led the pack, shelling out $2 billion—largely to market its anti-inflammatory drugs Skyrizi and Rinvoq, which alone earned the company over $5 billion in Q1 of 2025.

AbbVie’s chief commercial officer Jeff Stewart admitted during a May conference that new restrictions could force the company to “pivot,” possibly by shifting marketing toward disease awareness campaigns or digital platforms.

Pharma’s deep roots in broadcast advertising—making up 59% of its ad spend in 2024—suggest the impact could be dramatic. That shift would mark a reversal of policy changes made in 1997, when the FDA relaxed requirements for side-effect disclosures, opening the floodgates for modern TV drug commercials.

Supporters of stricter oversight argue that U.S. drug consumption is inflated because of these ads, while critics warn of economic consequences. Jim Potter of the Coalition for Healthcare Communication noted that reinstating tougher ad rules could make broadcast placements “impractical.” Harvard professor Meredith Rosenthal agreed, adding that while ads sometimes encourage patients to seek care, they can also push costly brand-name drugs over generics.

Beyond disclosure rules, the administration is considering changes to the tax code—specifically eliminating the industry’s ability to write off advertising as a business expense. This idea was floated during talks over Trump’s original tax reform but was ultimately dropped from the final bill.

Continue Reading

International

Judiciary explores accountability options over Biden decline ‘coverup’

Published on

Former President Joe Biden salutes the departure party before boarding Special Air Mission 46 at Joint Base Andrews, Md., Jan. 20, 2025. 

From The Center Square

By

No obvious solutions emerged during a congressional hearing Wednesday on how to hold those accountable for the alleged cover-up of President Joe Biden’s mental and cognitive decline, but witnesses had some suggestions for how to prevent similar situations in the future.

Republicans have been adamant for some time that Democratic lawmakers, the prior administration, the legacy media and those closest to Biden conspired to hide the former president’s mental and cognitive decline from the American people. More recently, allegations have surfaced that some of Biden’s staff or potentially others may have used an autopen – a machine that can replicate signatures – to sign official documents for Biden without his knowledge or consent.

From the Senate Judiciary Committee hearing on June 18th, 2025

Wednesday’s witnesses agreed that further investigation needs to be done into these questions. Republicans also explored what can be done after the fact and how to prevent similar events from happening in the future. The Senate Judiciary Committee’s hearing into those questions Wednesday’s boycotted by all but one Democrat.

Republicans didn’t miss the opportunity to call them out for it. U.S. Sen. Eric Schmitt, R-MO, said Democrats’ absence and their failure to call any witnesses to testify was “deeply disappointing” but “not surprising.”

“Their absence speaks volumes – an implicit admission that the truth is too inconvenient to face,” Schmitt said. “This de facto boycott is not just a refusal to participate. It’s a refusal to serve the American people who deserve answers about who was truly leading their government.”

From the Senate Judiciary Committee hearing on June 18th, 2025

Much of the hearing’s discussion revolved around proper uses of the autopen, which witnesses testified can only be rightfully used when the president specifically delegates its use to the user. The committee also discussed Section 4 of the 25th Amendment to the Constitution, which talks about succession in the case of a president becoming unfit or unable to fulfill the role. The amendment authorizes the vice president and a majority of the president’s cabinet to declare the president unfit, though that declaration has to be validated by a vote from Congress in order to have any effect.

What’s missing, however, is a clear manner of recourse for lawmakers or the public if those around the president fail to act despite plain signs he is incapable of holding office. Republicans wanted to know what they could do to prevent the alleged conspiracy from simply fading into history without consequences for any involved.

“As a government, it is imperative that we have clear contingency plans when emergency strikes, and yes, it is an emergency when we have a sitting president who is unable to discharge the duties of that office,” said U.S. Sen. John Cornyn, R-TX.

He asked witness Theo Wold, a visiting fellow for law and technology policy with The Heritage Foundation and who worked in the previous Trump administration, if any criminal statutes could be applied to those who are found to have participated in the alleged cover-up.

“In this case, some have suggested that there may be potential crimes committed by members of the Cabinet for failing to act basically, suborning perjury, forging, forging government documents, impersonating a federal officer, making false statements, conspiracy to defraud the United States, obstruction of justice, wire or mail fraud…  Do you think there’s any application of any of those criminal statutes to the circumstances of the Biden presidency?” Cornyn asked.

“There very well could be,” Wold said, but he added that it would be “a question for a prosecutor to take up in their discretion.”

While witnesses agreed that anyone participating in a cover-up should be held accountable, the solutions for doing so weren’t as clear as recommendations for how to prevent similar situations in the future.

John Harrison, James Madison Distinguished Professor of Law at the University of Virginia, didn’t see an obvious method of redress for what already happened but suggested that Congress perhaps require greater documentation of presidential actions going forward.

Wold provided additional suggestions, such as a revival of discussion around “other guardrails” that can be imposed on the 25th Amendment. There was lively debate toward the end of Ronald Reagan’s presidency about adding a mental health professional to the White House medical team or “whether the surgeon general should oversee the inclusion of medical reporting as part of… the 25th Amendment,” according to Wold. But he said there hadn’t been serious discussion since on how to improve the amendment. He also agreed with Sen. Katie Britt, R-AL, that some of the terms in the amendment, like “unable,” should be more clearly defined.

Continue Reading

Trending

X